Autolus Therapeutics plc (AUTL) Operating income 2017–2025
Autolus Therapeutics plc (AUTL) annual operating income history from SEC filings — each fiscal year as reported.
-$270.5MFY2025 · since FY2017: -$23.4M → -$270.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$270.5M | -12.1% |
| FY2024 | -$241.4M | -34.3% |
| FY2023 | -$179.7M | -25.3% |
| FY2022 | -$143.4M | -1.7% |
| FY2021 | -$141.1M | +16.1% |
| FY2020 | -$168.1M | -15.1% |
| FY2019 | -$146.1M | -153.9% |
| FY2018 | -$57.5M | -145.7% |
| FY2017 | -$23.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AUTL financial trends
AUTL RevenueAUTL Net incomeAUTL Net marginAUTL Gross profitAUTL Gross marginAUTL Operating marginAUTL Operating cash flowAUTL Free cash flowAUTL Capital expendituresAUTL Return on equityAUTL Stock buybacksAUTL Dividends paidAUTL Total assetsAUTL Total liabilitiesAUTL Shareholders’ equityAUTL overview →